Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine

JA Duce; X Zhu; LH Jacobson; PM Beart

Journal article

Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine

JA Duce, X Zhu, LH Jacobson, PM Beart

British Journal of Pharmacology | WILEY | Published : 2019

DOI: 10.1111/bph.14767

Download PDF

Abstract

Linked Articles: This article is part of a themed section on Therapeutics for Dementia and Alzheimer's Disease: New Directions for Precision Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.18/issuetoc.

University of Melbourne Researchers

Laura Jacobson Author

Related Projects (2)

DETERMINING THE CONTRIBUTION OF OREXIN RECEPTOR SUBTYPES TO SLEEP ARCHITECTURE

Sleep is an essential process that follows a regular pattern every night. The brain orexin system is a promising new target for sleep-induci..

TARGETING AUTOPHAGY TO IMPROVE PROTEIN METABOLISM IN ALS

One common feature of MND is the accumulation of protein deposits inside nerve cells which leads to their death. We have identified a potent..

Grants

Awarded by Alzheimer's Association

Funding Acknowledgements

J.A.D is supported by core institutional funding from Alzheimer's Research UK. X.Z. is supported by the Alzheimer's Association (AARG-16-443584). L.H.J. is supported by the Alzheimer's Association (2016-NIRG-396905) and NHMRC Australia (APP1105284). P.M.B. was supported in part by NHMRC Australia (APP1104295). The Florey Institute of Neuroscience and Mental Health receives infrastructure support from the Victorian State Government (Australia).